key: cord-0695564-go4s1dw2
authors: Fadipe, Babatunde; Oshodi, Yewande O.; Umeh, Charles; Aikomo, Kehinde; Ajirotutu, Omotayo Francis; Kajero, Jaiyeola; Fashanu, Chizoba; Adeoye, Adefemi A.; Coker, Ayodele Olurotimi; Sokunbi, Modupe; Nyamali, Veronica Oluyemisi; Ajomale, Tolu; Gbadebo, Adesoji; Oni, Adedapo; Keshinro, Ajibola Oladimeji; Ngozi Ejiegbu, Teniola Anne; Bowale, Abimbola; Akase, Iorhen E.; Mutiu, Bamidele; Adebayo, Bisola; Abdus-Salam, Ismail; Bode, Chris; Osibogun, Akin
title: Psychosocial Health Effects Of Covid-19 Infection On Persons In Treatment Centers In Lagos, Nigeria
date: 2021-06-15
journal: Brain Behav Immun Health
DOI: 10.1016/j.bbih.2021.100284
sha: 9e61fff4879103b074e90216b93ea447c72bb271
doc_id: 695564
cord_uid: go4s1dw2

INTRODUCTION: Prior research has highlighted the psychosocial impact of infectious diseases on individuals and the community at large. However, little is known about the psychosocial implications of COVID-19. This study set out to determine the rate as well as correlates of anxiety and depressive symptoms among persons managed as in-patients for COVID-19 in Lagos, Nigeria. MATERIALS AND METHODS: We conducted an online survey between April to June ending 2020 using a consecutive sampling technique of persons positive for COVID-19 and who were managed as in-patients across five (5) treatment centers in Lagos, Nigeria. The survey collected information on demographic as well as clinical data including suicidality. Anxiety and depressive symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). RESULTS: There were one hundred and sixty participants in total. The mean age of respondents was 36.4 (±9.7) years with a higher proportion (56.9%) being males. With regards to diagnosis, 28.1% and 27.5% of the respondents were categorised as probable cases of depression and anxiety respectively, while 3.8% respondents reported suicidal ideation. Majority of the respondents (61.9%) reported the fear of infecting their loved ones. The variables that showed association with psychiatric morbidity were a past history of an emotional concern, employment status, guilt about infecting others and boredom. CONCLUSION: This study revealed a high burden of psychological/psychiatric morbidity among persons treated for COVID-19, particularly persons who have had prior emotional concerns. The findings from this study reiterate the need to pay attention to the mental health of people during disease outbreaks and to incorporate psychosocial interventions as part of the management package.

On the 21 st of December 2019, pneumonia of unknown etymology was recorded to have started spreading among the inhabitants of Wuhan in Hubei Province of China (Rodríguez-Rey et al., 2020; World Health Organization (WHO), 2020). It was determined that these symptoms were caused by a beta coronavirus, SARS-CoV-2, and the resultant disease was eventually referred to as COVID-19 (Santos, 2020; World Health Organization (WHO), 2020). On the 30 th of January, the World Health Organisation (WHO) declared the COVID-19 outbreak a public health emergency of international concern (World Health Organization (WHO), 2020). Subsequently, COVID-19 swept across the globe and on the 11 th of March 2020 the WHO declared the outbreak a global pandemic (World Health Organization (WHO), 2020). As of the 22 nd of April, 2021, there were over 143 million recorded infected cases and approximately 3,051,000 COVID-19 related deaths globally ((World Health Organization (WHO), 2020).

The first case of COVID-19 in Nigeria was reported and isolated on the 27 th of February, 2020 and the country has experienced a steady rise in the number of infected cases till date. On 30th March 2020, the Federal Government of Nigeria imposed an initial strict 2-weeks lockdown, which was subsequently extended, to curb the spread of coronavirus and there are currently over 164,000 confirmed cases and globe (Chong et al., 2004; Huremović, 2019) . Prominent themes such as stress, anxiety, sadness, anger and stigmatization among infected individuals were observed (Maunder et al., 2003; Zheng et al., 2005) .

As with previous disease outbreaks, the rapidly increasing numbers of COVID-19 infections, its attendant growing mortality rate as well as the social restrictions (self-isolation, quarantines, lockdowns) imposed as control measures have been reported to result in psychological breakdowns (Brooks et al., 2020; Wang et al., 2020) . People infected with COVID-19, as it was with the SARS outbreak, may experience a fear of infecting others, getting ill, dying, job loss, social exclusion and separation from loved ones by being placed in isolation. Additionally, they may feel angry, confused, helpless, lonely, and experience anxiety, depression or posttraumatic stress disorder/posttraumatic stress symptoms(PTSD/PTSS) (Brooks et al., 2020) . Oftentimes, patients who suffered from prior mental health issues found it difficult to cope, as this was observed to lead to the worsening of pre-existing mental disorders and so should be considered as high risk (Santos, 2020) .

The psychological effects of the COVID-19 pandemic are likely to rise with increasing reports of death, media reporting, as well as the number of new cases. More studies will have to be conducted to get a full understanding of the psychological effects of this pandemic. Considering the recent onset of the COVID-19 outbreak, very few studies have focused on the ensuing psychological implications among patients, their carers (formal and informal) as well as the larger community. Currently, studies on this topic are limited in the literature especially in our environment, Nigeria; a country reputed to be the most populous country in Africa Therefore, this study was designed to examine and explore the psychiatric and psychological burden of the COVID-19 pandemic among a subset of individuals diagnosed with and J o u r n a l P r e -p r o o f managed for COVID-19 as in-patients over a twelve week period across treatment centres in Lagos Nigeria.

The study was a cross-sectional descriptive study that was conducted among persons who were diagnosed with COVID-19 and managed as in-patients. All eligible and consenting respondents were sampled for data collection during the duration of the study. Data was obtained via electronic means including

WhatsApp and text messaging in order to mitigate the risk of researchers being infected with COVID-19.

The research was carried out among people diagnosed with and treated for COVID-19 at the Lagos state designated treatment centres within the Lagos metropolis, Nigeria. As at the time of data collection, five (5) centres had been identified as treatment centres for COVID-19 including the Infectious Diseases Hospital (IDH), Yaba Lagos and the Lagos University Teaching Hospital among others. All of the isolation centres are government-funded hospitals and designated for use by all citizens of the country and foreigners. Between April and June ending 2020, which was the period of this data collection, the psychosocial response team had followed up a total 1183 inpatients while there had been over 14000 positive cases of COVID-19 diagnosed in Lagos, Nigeria.

The inclusion criteria for the study were individuals with an established diagnosis of COVID-19 using the polymerase chain reaction (PCR) technique, undergoing treatment for COVID-19 at one of the designated treatment centres and who had been on admission for up to five (5) days, had access to an internetenabled mobile phone to allow them respond to the questions and those who were clinically stable to answer questions. Potential participants who were too sick to participate in the study as well as those who did not possess an internet-enabled device were excluded from the study. All eligible individuals were approached and only those who gave informed consent were recruited into the study. Data collection was J o u r n a l P r e -p r o o f over a twelve week period. All data was obtained by sending the link to the questionnaire via electronic means, including: WhatsApp and text messaging.

A questionnaire was designed to elicit some socio-demographic and clinical data. Some of the variables collected included age, gender, marital status, employment status and a previous history of emotional health concerns. The respondents were also presented with a number of possible concerns that they may have following infection with COVID-19 such as having guilt feelings about infecting their loved ones, fear of dying etc

The Hospital Anxiety and Depression Scale (HADS) is a frequently used self-rating scale developed to measure anxiety and depression in a general medical population of patients. It is simple, easy to administer and takes 2 -5 minutes to complete. It consists of two subscales; anxiety and depression with a total of 14 items; seven items for the anxiety subscale (HADS Anxiety) and seven for the depression subscale (HADS Depression). HADS anxiety focuses mainly on symptoms of generalized anxiety disorder and HADS Depression is focused on anhedonia, the main symptom of depression (Snaith, 2003) .

Each item was scored on a four-point response-scale with scores ranging from 0 to 3. Six items on the scale were reverse scored and all the responses were summed to obtain the total score on either subscale.

Respondents who scored 8 and above on either the anxiety or depression subscales were categorized as having either probable anxiety or depression respectively (Bjelland et al., 2002; Zigmond & Snaith, 1983) . Such respondents were referred to as "cases" while those who did not were categorised as "noncase". Subscales were further categorised as mild (8 -10), moderate (11) (12) (13) (14) or severe (>15). The HADS was administered to all the respondents. Respondents previous history of emotional health concerns was assessed by asking them to tick either Yes or No to the question: "Have you had any concern about your mental or emotional health in the past to the extent that you considered seeking treatment"?

Potential participants were recruited electronically (WhatsApp and text messaging) in the course of the psychosocial support service that was given to them by members of the Lagos COVID psychosocial team.

The average response time for the questionnaires was estimated by the researchers to be about five J o u r n a l P r e -p r o o f minutes. The Psychosocial team was multidisciplinary in composition with different cadres of the mental health field and lay persons as volunteers. Training of team volunteers was provided on some key areas relevant to the diagnosis and treatment of COVID-19, Infection prevention and control, psychological first aid, breaking of bad news, coping skills, phone etiquette. Guidance was developed for calls and a system for call log reporting was put in place. Psychological support as indicated was given remotely to the affected persons and their significant others during isolation and care. There were different responses to the routine calls by the participants; while some were appreciative a few others were displeased with the calls. However, members of the psychosocial team had been trained not to bother persons who did not desire the service. The respondents were assessed prior to any form of intervention by members of the psychosocial support team.

All the patients were consecutively recruited by their respective case workers over the phone. The case workers emphasized the voluntary nature of their responses and reassured that their decision to decline would have no untoward effects on the quality of care that they would receive from the psychosocial team. Only those who gave consent for the study were recruited and sent links to the consent document and questionnaire, unwilling persons still received support as usual without any discrimination to them.

The calls were held in private spaces by the psychosocial team members assigned to each patient as per call protocols, this was to ensure privacy and confidentiality of the discussions.

Ethical approval (approval number -LUTHHREC/EREV/0420/14) was obtained from the health research and ethics committee (HREC) of the Lagos University Teaching Hospital (LUTH). Informed consent was obtained from all the eligible participants. There was a clear opportunity for all eligible participants to accept or decline to participate in the study and non-participation did not have any untoward effects on the support that they received. All the respondents who were categorised as cases as well as those who reported having suicidal ideation were referred to the crisis management team of the COVID-19 psychosocial response team for further review and follow-up.

Data analysis was done using SPSS-20. The primary outcome or dependent variables were the severity of anxiety and depression symptoms as determined by HADs. Descriptive analyses were carried out using J o u r n a l P r e -p r o o f frequency tables; percentages, mean and to determine prevalence. Comparative analyses were done using chi-square and t-tests to determine associations, and to identify associated factors while the p-value was set at <0.05.

About a third (36.2%) of respondents were health workers including medical doctors, nurses, surveillance officers and ambulance staff, who were also admitted into the hospital after testing positive for COVID-19. About a fifth (19.7%) of the respondents reported a history of emotional health problems. Other sociodemographic and clinical variables are as depicted in Tables 1 and 2. Regarding diagnosis using the HADS, 45 (28.1%) of the respondents met criteria for probable depression while 44 (27.5%) met criteria for probable anxiety disorder (Figure 2 ). In terms of severity of depressive symptoms (Table 3) , 28(17.5%), 14(8.8%) and 3(1.9%) of all the respondents were categorised as mild, moderate and severe respectively while on the other hand, 22(13.8%), 13(8.1%) and 9(5.6%) respondents J o u r n a l P r e -p r o o f fulfilled criteria for mild, moderate and severe forms of anxiety respectively. Twenty-five (15.6%) of all the respondents met cut-off for both probable anxiety and depression. 

Following bivariate analysis of all the sociodemographic and clinical variables described, there was an association between respondents' employment status and probable depression ( 2 =4.352, p=0.037) as thirty-eight (25.7%) of respondents who were employed had probable depression compared with seven (58.3%) of those who were unemployed. Additionally, having previous emotional health concerns J o u r n a l P r e -p r o o f showed a statistically significant relationship with both probable anxiety and depression ( 2 =3.868, p=0.049). Eighteen (39.1%) of the respondents who reported a history of an emotional concern had symptoms of an anxiety disorder compared with 26 (22.8%) of those without ( 2 ,= 4.380, p=0.036) while 18 (39.1%) of the respondents who had a history of an emotional concern had symptoms of a depressive disorder compared with 27(23.7%) of those without.

With regards to the respondents concerns, we found association between respondents' experience of boredom and probable anxiety ( 2 =5.842, p=0.016) as 21 (39.6%) of respondents who reported being bored had probable anxiety compared with 23 (21.5%) of those who did not report being bored. Twenty three (38.3%) of the respondents who reported having guilty feeling of infecting others had probable anxiety compared with 21 (21.0%) of those who did not. The relationship between having guilt feelings of infecting others with COVID-19 and having probable anxiety was statistically significant ( 2 =5.651, p=0.017). As is depicted in tables 4 and 5, we found no further association between all the other concerns reported by the patients and probable anxiety or depression. 

This study presents our findings on the mental wellbeing of persons hospitalized on account of COVID-19 infection. Notably, our study provides an insight into the experience of probable depression and anxiety by persons hospitalized on account of COVID-19 infection in Lagos, Nigeria thereby adding to the body of knowledge on the impact of the COVID-19 pandemic.

The demographic parameters revealed that the participants in this study had a mean age of 36 years which is similar to the findings reported in the first report on patients managed for COVID-19 in Nigeria who reported mean age of their participants as 38 years (Bowale et al., 2020) . Additionally, as was reported in the study by Bowale and colleagues, (2020) , our study participants included more males (56.9%) compared to females. This supports the earlier reports of the probable vulnerability of males to the COVID-19 infection (Jordan et al., 2020; Sharma & Volgman, 2020) . Several factors have been suggested as reasons for the increased vulnerability of males to COVID-19 including higher rates of smoking and its associated co-morbidities (Jordan et al., 2020; Livingston & Bucher, 2020) . Majority of the respondents in our study were either young or in their middle ages (< 45 years old) and were employed (92.5%) which reflects the enormous impact that the COVID-19 pandemic may have on the productive age group within the society. Earlier reports on the management of the COVID-19 among patients in Nigeria had reported a median hospital stay of 12 days supporting the huge toll that this may have on both the individuals and their productivity considering that persons hospitalized are not able to engage in any fruitful work during the period of illness, hospitalization as well as recovery (Bowale et al., 2020) .

About three in ten respondents (28.1%) in our study met criteria for probable depression and were categorised as cases using the HADS which is several-fold the proportion of depression among the general population of inhabitants of Lagos as reported in an earlier study by Adewuya et al., (2018) who J o u r n a l P r e -p r o o f recorded a depression prevalence of 5.5% in a household survey of 11, 246 adults in Lagos

Nigeria (Adewuya et al., 2018) . There are limited studies looking at depression prevalence among patients with COVID-19, however, Zhang and colleagues (2020) also found a similar prevalence of depression among this population put at 29.2% in China (Zhang et al., 2020) . A hospital-based study of attendees of a general practitioner clinic that was conducted in Northern Nigeria using the HADS reported findings that are similar to ours with the rate of depression being 24.9%; however, in their study 21.2%, 3.55% and 0.2% of their respondents met criteria for mild, moderate and severe forms of depression (Sanni et al., 2018) compared to 17.5%, 8.8% and 1.9% reported in our study. The finding of higher rates in our sample may reflect the huge effect of COVID-19 on an individual's mental health compared to some other medical conditions that may also warrant presentation to hospitals.

This study findings with regards to the burden of probable anxiety is also similar to that of probable depression with equally about three in ten (27.5%) of the respondents in this study, meeting criteria for a probable anxiety disorder based on HADS. In China, a prevalence of 20.8% was reported for anxiety among Chinese who were COVID-19 positive (Zhang et al., 2020) and this is not too far from the findings from this current study. Again, compared with the general population, this is several folds the rate of anxiety reported by Adewuya and colleagues (2018) who found a far lower prevalence rate of 3.5% among inhabitants of Lagos, Nigeria (Adewuya et al., 2018) . The relatively high prevalence of probable anxiety and depression in this study compared with that of the general population may be attributable to both the direct and indirect effects of COVID-19 infection even though this is not fully understood presently (Vindegaard & Benros, 2020) .

A recent study that was conducted among patients hospitalized on account of COVID-19 in China reported that 34.72% and 28.47% of their 144 respondents had symptoms of anxiety or depression, respectively (Kong et al., 2020) . The findings from the study by Kong and colleagues align with ours and reveal the extent of emotional burden that patients with COVID-19 have to endure. It was interesting to note that almost a fifth of the respondents in our study had significant co-morbid anxiety and depression symptoms suggesting that a major proportion of patients with COVID-19 may also have to endure comorbid mental health concerns that may contribute to their overall morbidity and affect treatment outcome. Studies have highlighted the deleterious impact that emotional disorders including anxiety and depression can have on the outcome of other disease processes (Hamer et al., 2019; Oliveira et al., 2019; Pompe et al., 2018) . It is also important to note that studies have shown that these mental health conditions may persist beyond the period of treatment for COVID-19. In a study of SARS-CoV-1 patient population in Hong Kong, the authors reported various psychiatric symptoms including depression and anxiety disorders among a sample of survivors using clinical interviews (Lam et al., 2009 ).

Six (3.8%) of the respondents in our study reported suicidal ideation by acknowledging that they felt that they would be better off dead. A study using data for 40,469 COVID-19 positive adult patients derived from a network of health care organizations (TriNetX database) revealed that 0.2% of the patients had suicidal ideation (Nalleballe et al., 2020) . The higher rate of suicidality found in our study may be due to a number of reasons; the fact that the patients in our study were on admission may suggest that they had (Kawohl & Nordt, 2020) .

Contrary to the study conducted by Kong and colleagues in China (2020) , the only variables that were associated with either anxiety or depression in our study include a past history of emotional concern, employment status, experience of being bored and having guilt feeling of infecting others (Kong et al., 2020) . Going by the findings in our study, unemployed respondents reported significantly higher rates of depressive symptoms compared to those who were employed suggesting that employment may be a protective factor in this regard. It is also possible that being unemployed may have been a risk factor for depression among these respondents even prior to becoming infected with COVID-19. Further, we found that respondents who acknowledged having prior concerns about their emotional wellbeing reported significantly higher rates of anxiety and depression compared to those who responded otherwise suggesting the need to have a high index of suspicion for exacerbation of mental health problems among persons with previous concerns. With regards to the respondents concerns, those who reported experience of boredom also reported higher levels of anxiety symptoms. While it may be difficult to determine the exact relationship between boredom and anxiety symptoms, it is possible that persons who were on admission were more likely to focus on their prevailing circumstances as a result of being bored which in itself may serve as a stressor to provoke and anxiety response. Additionally, having guilt feeling of infecting others with COVID-19 was also more likely to be associated with higher levels of anxiety symptoms. It is likely that the experience of guilt surrounging COVID-19 puts vulneralble persons under significant strain as to trigger an anxiety response. Finally, It is possible that we did not find any more correlates for anxiety or depression as we examined only a few sociodemographic or clinical variables to avoid overburdening the respondents who were hospitalized.

Our study is not without some limitations. Firstly, we employed a non-probability sampling technique which may have introduced bias into the selection of respondents. Also, we did not have a control group thus weaking our ability to determine the true effects of COVID-19 on our study population. The questionnaires were respondent based and the respondents may have given responses that they considered desirable. The study is also cross-sectional in design and this precludes determination of causality. Some of the participants may have had pre-COVID-19 history of a psychiatric disorder and there was no provision for the exclusion of such. It is also important to note that in assessing past history of emotional health concerns; the question may have been vague and may have been misinterpreted by the respondents which could therefore have affected their responses. This study employed the use of the HADs which is a screening instrument and cannot reliably be used to make a diagnosis of either anxiety or depressive disorders. Despite the limitations, one major strength of our study is the fact that it is a pace setter, being the first study as far as we are aware of in this environment to examine the mental health implications of COVID-19 among patients diagnosed and hospitalized on account of the disease. Also, the study was conducted among respondents across all the isolation centres in Lagos as at the time of the data collection.

This study demonstrated that Nigerians that were infected with the Covid-19 virus also manifested with anxiety and depressive symptomatology. Findings from this our study can be used to inform decisions regarding mental health intervention strategies such that persons at risk of psychological distress during disease outbreaks can be better assisted in coping with the situation both in Nigeria and indeed globally.

Our study highlights the need to pay attention to the mental health of patients diagnosed with COVID-19.

incorporate psychosocial interventions as part of treatment during disease outbreaks and the need for mental health professionals to be considered as a standard part of multidisciplinary teams in the care of patients.

Finally, there is a need for more robust studies with larger sample sizes as well as longitudinal studies to examine the enormity of the mental health impact of COVID-19 pandemic on patients.

This study was funded by individual members of the research team as there was no external funding available.

The authors have no conflicts of interest to report.

Current prevalence, comorbidity and associated factors for symptoms of depression and generalised anxiety in the Lagos State Mental Health Survey (LSMHS)

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Psychological impact of severe acute respiratory syndrome on health workers in a tertiary hospital

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic -United States

Psychological distress and infectious disease mortality in the general population

Brief History of Pandemics (Pandemics Throughout History)

Covid-19: risk factors for severe disease and death

COVID-19, unemployment, and suicide. The Lancet

Influenza pandemics of the 20th century

Prevalence and Factors Associated with Depression and Anxiety of Hospitalized Patients with COVID-19

Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors

Coronavirus Disease 2019 (COVID-19) in Italy

The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital

Spectrum of neuropsychiatric manifestations in COVID-19

Nigerian Center for Disease Control (NCDC). (n.d.). COVID 19 Nigeria

The Impact of Anxiety and Depression on the Outcomes of Chronic Low Back Pain Multidisciplinary Pain Management-A Multicenter Prospective Cohort Study in Pain Clinics with One-Year Follow-up

The Impact of Anxiety and Depression on Surgical and Functional Outcomes in Patients Who Underwent Radical Prostatectomy

Psychological Impact and Associated Factors During the Initial Stage of the Coronavirus (COVID-19) Pandemic Among the General Population in Spain

Epidemiology of Depression in a Primary Care Setting in North Central Nigeria

Reflections about the impact of the SARS-COV-2/COVID-19 pandemic on mental health

Sex Differences in Mortality From COVID-19 Pandemic Are Men Vulnerable and Women Protected? JACC: Case Reports

The psychological impact of SARS: a matter of heart and mind

The Hospital Anxiety And Depression Scale

COVID-19 pandemic and mental health consequences: Systematic review of the current evidence

Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China

Coronavirus disease (COVID-19) Situation Report -209

The differential psychological distress of populations affected by the COVID-19 pandemic

Exploratory study on psychosocial impact of the severe acute respiratory syndrome (SARS) outbreak on Chinese students living in Japan

The hospital anxiety and depression scale

The team acknowledges the enormous support of the Governor of Lagos state, Mr Babajide Sanwoolu; The honorable Commissioner for Health, Professor Akin Abayomi and the Incident manager, Dr Ismail Abdus-Salam

The following persons who are members of the Psychosocial support pillar were very supportive during the period of data collection and patient support: Boluwatife Oyatokun, Aladejare Samuel, Lawrence Adenike, Taiwo Dr Babatunde Fadipe (MBBS, MSc, FWACP) is an early career psychiatrist and a consultant psychiatrist at the Lagos University Teaching Hospital, Idi-Araba, Lagos where he is involved in rendering clinical service, teaching and research. In the last few years, his practice and research has focused on psychosocial issues in health and among underserved populations, stigma, addiction, consultation-liaison and mental health advocacy.He is a graduate of the College of Medicine, University of Ibadan. He holds a Master's degree in Public Health (Epidemiology) from the University of Lagos and also holds certificates in addiction studies and international community health from the universities of Amsterdam and Oslo respectively. He is a fellow of the Faculty of Psychiatry in the West African College of Physicians.He is an affiliate in research at Kings College, London and a member of the INDIGO network, a collaboration of research colleagues in over 30 countries worldwide committed to developing knowledge about mental illness related stigma and discrimination. He served as a member of the Lagos COVID-19 psychosocial response team; a group tasked with providing emotional support for individuals diagnosed with COVID-19, their relatives, frontline staff and members of the community.He has presented several papers at both local and international conferences and has a good number of publications in peer-reviewed journals. He also serves as a peer-reviewer for learned journals in various areas of psychiatry. He is a recipient of numerous awards including the international travel fellowship of the American Academy of Addiction Psychiatrists, Early Career Fellowships of the World Psychiatric Association and the Academy for Eating Disorders to mention a few. He enjoys travelling, swimming among others.J o u r n a l P r e -p r o o f